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Objectives: To compare duration and changes over time in length 
of hospital stay for very preterm and extremely preterm infants in 
10 European regions.
Design: Two area-based cohort studies from the same regions in 
2003 and 2011/2012.
Setting: Ten regions from nine European countries.
Patients: Infants born between 22 + 0 and 31 + 6 weeks of ges-
tational age and surviving to discharge (Models of Organising 
Access to Intensive Care for Very Preterm Births cohort in 2003, 
n = 4,011 and Effective Perinatal Intensive Care in Europe cohort 
in 2011/2012, n = 4,336).
Interventions: Observational study, no intervention.
Measurements and Main Results: Maternal and infant characteris-
tics were abstracted from medical records using a common pro-
tocol and length of stay until discharge was adjusted for case-mix 
using negative binomial regression. Mean length of stay was 63.6 
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days in 2003 and varied from 52.4 to 76.5 days across regions. 
In 2011/2012, mean length of stay was 63.1 days, with a nar-
rower regional range (54.0–70.1). Low gestational age, small for 
gestational age, low 5-minute Apgar score, surfactant adminis-
tration, any surgery, and severe neonatal morbidities increased 
length of stay. Infant characteristics explained some of the dif-
ferences between regions and over time, but large variations 
remained after adjustment. In 2011/2012, mean adjusted length 
of stay ranged from less than 54 days in the Northern region of 
the United Kingdom and Wielkopolska, Poland to over 67 days in 
the Ile-de-France region of France and the Eastern region of the 
Netherlands. No systematic decrease in very preterm length of 
stay was observed over time after adjustment for patient case-mix.
Conclusions: A better understanding of the discharge criteria and 
care practices that contribute to the wide differences in very pre-
term length of stay across European regions could inform policies to 
optimize discharge decisions in terms of infant outcomes and health 
system costs. (Pediatr Crit Care Med 2018; 19:1153–1161)
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Very preterm infants require care in specialized neonatal units before they can be discharged home. Their length of stay (LOS) in hospital is influenced primarily by their 
gestational age (GA) at birth and medical conditions leading to 
longer stays, for example, bronchopulmonary dysplasia (BPD), 
persistent apnoeic spells, or need for tube feeding (1–5). The 
family’s socioeconomic circumstances as well as the neonatal 
unit’s policies and other health system factors, including the 
supply of beds or the availability of postdischarge home care, 
may also influence LOS. Although many interventions in this 
high-risk population are standardized, guidelines concerning 
when to discharge a very preterm infant are rare, reflecting the 
absence of evidence-based, consensual criteria (6).
Prolonged stay in hospital lengthens exposure to risks asso-
ciated with the hospital environment, including nosocomial 
infections as well as noise and bright lights which may impact 
on future development (7). It may also disturb the establish-
ment of interactions between parents and the infant (6). On 
the other hand, discharging a very preterm infant too early 
may expose the infant to the risk of life-threatening events and 
increase the risk of rehospitalization (8, 9). From a health sys-
tem perspective, longer LOS reduces availability of beds and 
may limit the admission of other preterm infants to a neonatal 
ICU (NICU). LOS also determines healthcare costs, although 
other factors can offset the costs of longer hospital stays (10).
Trends toward shorter hospital stays have been observed for 
other hospital populations in industrialized countries, includ-
ing stay in hospital after birth at term (11). For very preterm 
infants, however, it is possible that improvements in survival 
may have led to higher LOS as more infants at very low GAs or 
with more severe health conditions survive to discharge (12, 
13). Some studies, however, show that morbidity among very 
preterm infants is declining, so survivors may be healthier and 
be discharged sooner (12–14). How these changing population 
characteristics affect the overall LOS for very preterm infants 
is not known.
The aim of this study was to compare LOS in hospital for 
very preterm infants across two time periods in European 
regions that have similar standards of living and social systems 
guaranteeing insurance coverage. We also sought to identify 
maternal, pregnancy, and newborn characteristics associated 
with variability in LOS. Data come from two area-based stud-
ies conducted in the same European regions in 2003 and 
2011/2012 (15, 16).
MATERIALS AND METHODS
Study Design and Population
This analysis used data from the Models of Organising Access 
to Intensive Care for Very Preterm Births (MOSAIC) and 
Effective Perinatal Intensive Care in Europe (EPICE) stud-
ies, which included all stillbirths and live births from 22 + 0 
to 31 + 6 weeks of GA. MOSAIC focused on comparing medi-
cal practices and the organization of care in European regions 
(15), whereas the primary aim of EPICE was to investigate how 
evidence-based medicine is introduced into the clinical care of 
very preterm infants (16). MOSAIC included 10 regions from 
nine countries, whereas EPICE included 19 European regions 
from 11 countries. All of the MOSAIC regions were included 
in the EPICE study, but several regions in France, Poland, 
and the United Kingdom had slightly different administrative 
boundaries. For this study, we included only the common geo-
graphic zones in both studies (see study flow chart, Fig. S1, 
Supplemental Digital Content 1, http://links.lww.com/PCC/
A775; legend: study flow chart showing numbers of infants 
eligible, excluded, and included). In both studies, recruitment 
occurred over a 12-month period, except for the French region, 
where the recruitment period was 6 months.
Investigators abstracted data from medical records in 
obstetric and neonatal units using a standardized ques-
tionnaire with common definitions that was pretested in 
all regions. The EPICE instrument was developed from the 
MOSAIC instrument, although modifications were made 
to achieve the new study objectives. Inclusions were cross-
checked against delivery ward registers in maternity units or 
another external data source. Infants were followed up until 
discharge home from hospital or into long-term care or death. 
The methodologies for the studies have been described in 
more detail previously (15, 16).
Study Population
The full MOSAIC cohort included 7,356 still and live births 
of which 7,125 occurred in geographic zones included in the 
EPICE project. Of these births, 5,133 were live births, 4,917 
were admitted to a NICU and 4,176 survived to discharge, 
representing 81.1% of live births and 56.3% of all births. The 
EPICE cohort included 10,329 births of which 7,009 were in 
common geographic zones. Of these, 5,265 were live births, 
5,079 were admitted to a NICU and 4,504 survived to dis-
charge, 85.5% of live births and 64.2% of all births. Infants 
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with missing location of discharge (n = 319) or missing date of 
discharge (n = 14) were not included in this study, but infants 
who were discharged into long-term institutional or foster 
care were included (n = 116; 1.4% of the sample). Infants 
with missing information on location of discharge were 4% 
of the total in both periods. The final study population com-
prised 4,011 infants surviving to discharge in 2003 and 4,336 
in 2011/2012 (Fig. S1, Supplemental Digital Content 1, http://
links.lww.com/PCC/A775).
Outcome and Covariables
The primary outcome measure was the length of hospital 
stay as calculated from the date of birth and the date of final 
discharge. Covariables were maternal and infant character-
istics likely to influence the duration of hospitalization and 
included maternal and pregnancy characteristics (multiple 
pregnancy, prenatal corticosteroids, cesarean delivery) and 
infant characteristics (GA at birth, sex, birthweight, birth-
weight percentile for GA [< 10th, 10–24th, ≥ 25th], and the 
5-min Apgar score). These covariables were selected based on 
the scientific literature assessing risk factors for long LOS, as 
well as previous studies from these cohorts identifying risk 
factors for adverse outcomes which could prolong stay in 
hospital (17–20). GA at birth was based on the best obstet-
ric assessment, according to information on last menstrual 
period and/or ultrasound measures. Birthweight for GA was 
computed based on the observed birthweight for GA distri-
bution in each cohort and reported in three groups previously 
found to be relevant for neonatal outcomes (19) Variables 
describing the neonatal course included any surfactant, sur-
gery for any reason, neurologic morbidity (intraventricular 
hemorrhage [IVH] grade III or IV according to the classifica-
tion Papile et al [21] and cystic periventricular leukomalacia 
[cPVL] documented on ultrasound or MRI scan), BPD (oxy-
gen dependency or ventilation [including nasal continuous 
positive airway pressure] at 36 wk of GA), and any congenital 
malformation. Variables were collected using similar defini-
tions with the exception of congenital malformations, for 
which more detail was available in the EPICE study, yielding a 
higher overall prevalence, which we believed to be principally 
linked to more thorough ascertainment of anomalies. This 
variable was therefore presented in descriptive tables, but not 
included in adjustment models.
Statistical Analysis
We first compared means and medians in LOS across peri-
ods and regions. Then we examined changes in the charac-
teristics of women and infants between 2003 and 2011/2012. 
In both periods, we analyzed the impact of these population 
characteristics on LOS. As LOS is not a normally distributed 
variable, we used a negative binomial model to estimate risk 
ratios, as recommended (22). We also calculated the adjusted 
predictions in number of days for each covariable, meaning the 
LOS that would be observed for infants with this characteris-
tic in a sample with the covariable profile of the overall study 
population. Adjusted models included all covariables. Region 
was entered as a fixed effect, and we adjusted for clustering of 
patients within region.
We then used our adjusted models to compare LOS across 
regions taking into consideration patient characteristics in 2003 
and in 2011/2012. We computed adjusted risk ratios for each 
region and time period by running one combined model with 
interaction terms for period on all covariables and predicted 
adjusted mean LOS for each region in each period. The esti-
mated mean LOS are those that would be observed if the infants 
born in each region in each period had the covariable profile 
observed in the overall study population. Using these adjusted 
means, we calculated the difference between the periods for each 
region, and we obtained CIs using the delta method (23).
Finally, we carried out a sensitivity analysis by running this 
final model using a more homogeneous lower risk sub-popula-
tion defined as infants born at 29 weeks or over without severe 
congenital anomalies or severe neonatal morbidity (IVH 
grades III/IV, cPVL, BPD, necrotizing enterocolitis, retinopathy 
of prematurity) or surgery during the neonatal hospitalization.
Ethics Approval
Ethics approval was obtained for both studies in each study 
region from regional and/or hospital ethics committees as 
required by national legislation. The European studies were 
also approved by the French Advisory Committee on Use of 
Health Data in Medical Research and the French National 
Commission for Data Protection and Liberties.
RESULTS
In 2003, the average LOS among survivors to discharge was 
63.6 days (median of 56 d), with a variation across regions 
from 52.4 days (median of 46 d) in Wielkopolska in Poland to 
76.5 days (65 d) in Hesse in Germany (Table 1). In 2011/2012, 
the overall mean and median were slightly lower (63.1 and 55), 
but there was no overall trend toward lower LOS; regional dif-
ferences remained substantial despite a narrowing of the range 
between regions at the extremes. The small reduction in overall 
LOS masked contrasting regional trends with sizable decreases 
in Hesse in Germany and Flanders in Belgium and increases in 
the Eastern-Central region of the Netherlands.
Table 2 compares the characteristics of very preterm survi-
vors to discharge in the two time periods. The proportion of 
infants born to older women, as part of a multiple set and to 
nulliparous women increased. More active perinatal manage-
ment was evidenced by changes in antenatal steroid use and a 
slightly higher proportion of cesarean deliveries. The GA dis-
tribution changed slightly with more survivors at lower gesta-
tions; more infants had low 5-minute Apgar scores. In contrast, 
the proportions of survivors with severe neurologic morbidity 
and BPD were significantly lower.
Table S1 (Supplemental Digital Content 2, http://links.lww.
com/PCC/A776) illustrates how maternal and infant character-
istics affected LOS in 2011/2012. GA at birth was strongly related 
to LOS, with an adjusted mean of 106.7 and 105.2 days for infants 
born at 23 and 24 weeks, respectively compared with 42.7 days at 
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31 weeks. Other risk factors and morbidities with a strong inde-
pendent impact on LOS were small for GA (adjusted mean of 
81.0 d for a birthweight percentile < 10th percentile compared 
with 58.2 d for a birthweight > 25th percentile), any surgery 
(adjusted mean of 77.5 d vs 59.4 d for no surgery), and BPD 
(adjusted mean of 74.5 d vs 58.8 d). Other significant predictors, 
but with a smaller impact, were a low 5-minute Apgar score, sur-
factant administration, and IVH-cPVL. The impact of these pre-
dictors on LOS was very similar in 2003 (Table S2, Supplemental 
Digital Content 3, http://links.lww.com/PCC/A777).
Patient characteristics contributed to the differences in 
LOS between regions as shown by changes in risk ratios after 
adjustment for population case-mix (Table 3). In particular, 
the extreme position in Hesse, Germany was reduced in both 
periods. On the other hand, the low LOS of the Netherlands in 
2003 appeared to be largely explained by its patient case-mix. 
Nonetheless, although these differences explained some of the 
variation, the range of the adjusted means was still over 2 weeks: 
51.0–71.8 days in MOSAIC and 52.8–68.0 days in EPICE. In 
general, the adjusted changes over time in mean LOS were less 
marked than unadjusted changes, with the exception of the 
Danish and Italian regions. We also observed large regional dif-
ferences in LOS in sensitivity analyses using a lower risk sam-
ple, from 37.1 to 53.6 days in MOSAIC and 33.4–51.3 days in 
EPICE (Table S3, Supplemental Digital Content 4, http://links.
lww.com/PCC/A778), with a high correlation between values 
in the overall and low risk population (Spearman rho of 0.95; 
p < 0.001 in MOSAIC and 0.92; p < 0.001 in EPICE).
DISCUSSION
In a large area-based study including more than 8,000 very 
preterm infants in two time periods, we observed a greater 
than 2-week difference in duration of neonatal hospitalization 
between regions with the lowest and highest mean LOS in both 
periods. Marked regional differences persisted after adjusting 
for maternal and infant characteristics. Although overall LOS 
remained largely stable, there were varying trends across time 
by region with decreases in Belgium, Denmark, Germany, and 
Italy and increases in France, the Netherlands, Portugal, and 
the United Kingdom. In general, regions with higher initial 
LOS experienced reductions, whereas those with lower initial 
LOS remained constant or increased which reduced some of 
the variation between regions over time. These regional dif-
ferences raise questions about how local and regional factors 
determine discharge decisions, whether differences in medical 
practices underlie LOS variation and what consequences these 
decisions have for health outcomes and costs.
Our study’s strengths include its population-based design, 
large sample size, use of a common standardized protocol to 
abstract data on perinatal characteristics, and neonatal mor-
bidity from medical records and the existence of data from 
the same geographical zones in two time periods. We were 
able to measure the entire length of hospitalization, which 
is not the same as the stay in the NICU (22). As organiza-
tion of neonatal care differs between regions and units, it is 
important to include infants who are transferred to another 
ward or to another hospital when they do not need further 
intensive care (24).
Limitations are the absence of some data items relevant for 
the investigation of discharge decisions, including the family’s 
socioeconomic status, whether infants were discharged with a 
feeding tube or oxygen and whether postdischarge home care 
was provided. Although we had a wide range of variables to 
describe case-mix, we did not have full information on each 
child’s morbidity risk profile, such as sepsis, extended need for 
TABLE 1. Length of Hospital Stay in the 10 European Regions in 2003 and 2011/2012
Country: Region
Models of Organising Access to 
Intensive Care for Very Preterm 
Births (2003)
Effective Perinatal Intensive  
Care in Europe (2011/2012)
Mean Difference 
2011/2012–2003  
(95% CI)n Mean (sd) Median (IQR) n Mean (sd)
Median  
(IQR)
Belgium:Flanders 461 68.6 (33.7) 61 (46–81) 641 63.4 (32.5) 54 (44–74) –5.1 (–8.6 to –1.6)
Denmark:Eastern 286 67.3 (31.3) 60 (48–79) 283 65.5 (42.9) 60 (39–77) 1.9 (–6.9 to –3.1)
France: Ile-de-France 712 67.0 (30.3) 61 (48–80) 656 65.8 (30.4) 60 (46–77) –1.2 (–3.9 to –1.6)
Germany: Hesse 544 76.5 (46.6) 65 (47–94) 534 70.1 (45.0) 59 (43–84) –6.4 (–10.8 to –1.9)
Italy: Lazio 361 60.3 (32.8) 53 (38–73) 470 57.9 (33.4) 49 (36–73) –2.4 (–6.5 to –1.7)
The Netherlands: East Central 300 58.2 (23.1) 51 (41–71) 328 67.0 (36.4) 58.5 (44–80) 8.8 (4.7–12.8)
Poland: Wielkopolska 213 52.4 (29.0) 46 (31–68) 242 54.0 (29.3) 47 (31–70) 1.6 (–3.6 to –6.8)
Portugal: Northern 188 55.2 (48.2) 46 (33–62) 247 60.0 (30.0) 53 (39–71) 4.8 (–0.7 to –10.3)
United Kingdom: Northern 349 57.0 (28.9) 50 (36–73) 353 60.3 (43.2) 50 (37–70) 3.3 (–1.1 to –7.7)
United Kingdom: former Trent 597 57.2 (31.7) 49 (34–72) 582 61.2 (32.7) 51.5 (38–80) 4.0 (0.6 to –7.5)
Total 4,011 63.6 (34.9) 56 (41–77) 4,336 63.1 (36.0) 55 (40–76) –0.4 (–1.7 to –0.9)
IQR = interquartile range.
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TABLE 2. Maternal and Infant Characteristics in 2003 and 2011/2012
Maternal and Infant Characteristics
Models of Organising 
Access  to Intensive 
Care for Very Preterm 
Births (2003) n = 4,011
Effective Perinatal 
Intensive Care in 
Europe (2011/2012)  
n = 4,336
pn % n %
Maternal characteristics
 Maternal age (yr)
  < 25 840 21.0 704 16.3 < 0.001
  25–29 1,093 27.3 1,177 27.2  
  30–34 1,234 30.8 1,347 31.2  
  35 + 834 20.8 1,095 25.3  
 Multiple birth 1,144 28.5 1,422 32.8 < 0.001
 Nulliparous 2,165 54.7 2,468 57.5 0.01
 Antenatal steroids (any) 3,133 80.5 3,838 89.5 < 0.001
 Cesarean section 2,543 63.7 2,926 68.0 < 0.001
 Foreign borna 838 22.1 880 22.0 0.943
Infant characteristics
 Gestational age (completed weeks)
  23 12 0.3 19 0.4 0.007
  24 72 1.8 131 3.0  
  25 161 4.0 207 4.8  
  26 272 6.8 295 6.8  
  27 344 8.6 407 9.4  
  28 516 12.9 522 12.0  
  29 625 15.6 657 15.2  
  30 878 21.9 900 20.8  
  31 1,131 28.2 1,198 27.6  
 Birthweight
  < 750 g 305 7.6 346 8.0 0.533
  ≥ 750 g 3,701 92.4 3,990 92.0  
 Small for gestational age (percentiles)
  < 10th 345 8.6 370 8.5 0.093
  10–25th 546 13.7 665 15.3  
  > 25th 3,107 77.7 3,301 76.1  
 Male 2,153 53.7 2,339 53.9 0.817
 5-min Apgar score < 7 469 12.6 610 15.0 0.003
 Surfactant 1,919 48.2 2,272 53.7 < 0.001
 At least one surgery 393 9.8 451 10.4 0.361
 Intraventricular hemorrhage III–IV or cystic 
periventricular leukomalacia
291 7.3 260 6.1 0.028
 Bronchopulmonary dysplasia at 36 wk 606 15.4 590 13.9 0.046
 Congenital anomaly 202 5.0 403 9.3 < 0.001
a In the United Kingdom, data are collected on ethnicity, rather than country of birth; we used self-defined foreign ethnicity.
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total parenteral nutrition, the number of congenital anomalies, 
and the complexity of surgical interventions. However, sensi-
tivity analyses among lower risk infants with a more homo-
geneous risk profile found similar differences across regions, 
suggesting that residual confounding does not explain these 
findings. Other limitations were the absence of data on read-
missions after discharge and on the unit practices that might 
contribute to variation as well as insufficient sample sizes 
within regions to analyze differences across units. Finally, our 
study questions related to infants surviving to discharge and 
averages for the regions based on all admissions, including in-
hospital deaths, would differ.
Patient factors were strong predictors of LOS, as found in 
previous studies, with GA at birth having a major impact (1, 4, 
5). The most immature babies born at 23, 24, and 25 weeks of 
gestation were hospitalized for over twice as long as those born 
at 30 to 31 weeks. Other predictors of a longer LOS in our sam-
ple were neonatal complications and morbidities, especially 
BPD and having at least one surgery, and also to a lesser extent, 
brain lesions, which is concordant with previous knowledge 
(25, 26). Being small for GA also increased LOS. In contrast, 
maternal sociodemographic and healthcare characteristics 
were not significant predictors. In this respect, our results 
contrast with a recent U.S. study that found that the absence 
of antenatal steroids prolonged LOS in very low birthweight 
infants (27). We also observed differences in patient case-mix 
over time with an increase in the proportion of the highest risk 
infants at very low GAs, but also a decline in some complica-
tions such as severe brain lesions and respiratory morbidity.
The variation in patient characteristics across regions had 
an impact on LOS, and this could be substantial in some 
regions. For instance, in the Netherlands, where unadjusted 
LOS over time increased most, the lower limit for active man-
agement of very preterm infants was lowered from 26 to 24 
weeks of gestation over this time period (14, 28). In 2003, this 
policy meant that unadjusted LOS was lower than in the other 
regions because of the small proportion of extremely preterm 
infants. This is illustrated by the large increase in LOS once 
patient characteristics were taken into consideration from 58.2 
to 63.7 days. Even after adjusting for case-mix, however, the 
LOS increased in the Netherlands over time which could reflect 
other residual changes in the case-mix that were not taken into 
consideration in our analyses. In Germany and the United 
Kingdom, adjusted LOS tended to be lower than unadjusted 
values suggesting care for a higher risk patient population, 
which may be related to more active management of the high-
est risk infants (28).
Although case-mix explained some of the variability 
observed in our study, wide regional differences persisted after 
adjustment, in line with observations from previous studies 
on regional and unit differences in LOS (4, 29). Multiple fac-
tors could explain these variations, including opinions among 
professionals about the optimal care for these infants and dif-
ferences in other practices that might lengthen stay, such as 
respiratory management or nutritional policies, which are 
known to vary across units (30). For instance, local mechanical 
ventilation and oxygenation strategies, including specific vari-
ables used by various units to wean exogenous oxygen or ven-
tilatory support may be a key determinant of LOS. A recent 
study found that implementing a collaborative quality initia-
tive to promote evidence-based practices for feeding, discharge 
planning and management of apnea, bradycardia, and oxygen 
desaturation events made it possible to reduce postmenstrual 
age at discharge in California NICUs (31).
Health system factors related to financing, demand for beds 
or organization of postdischarge care could also play a role. In 
a Swedish cohort where mean postmenstrual age at discharge 
differed by up to 2 weeks between hospitals, it was lower with 
breastfeeding and domiciliary care and in hospitals without 
fixed discharge criteria (32). In our sample, the Hesse region 
provides an example of the impact of financing as hospital 
reimbursement was restructured from a system based on per 
diem charges to diagnosis-related groups, starting in 2003 on 
a voluntary basis and becoming obligatory in 2004 (33, 34). 
In this region, case-mix adjusted mean LOS declined steeply 
between 2003 and 2011/2012 (71.8–65.1 d).
Interventions are increasingly implemented in neonatal 
units to promote safe, earlier discharge of very preterm infants, 
including individualized developmental care, more involve-
ment and preparation of parents for discharge, and routine 
discharge readiness assessment (35–39). Postdischarge organi-
zation of care, including hospital-assisted home care, can also 
reduce LOS in hospital (40). In contrast, gavage feeding of the 
infant at home has not yet been proven to successfully shorten 
the stay in hospital (41), while the effectiveness of prescrib-
ing monitors for use at home to shorten hospitalization is still 
debated (42). The usefulness of having models to predict LOS 
needs to be confirmed (1, 4, 25, 43). These regional differences 
may also make it possible to carry out research on the determi-
nants as well as the benefits and disadvantages of short versus 
longer LOS in terms of rehospitalization rates, parental satis-
faction, and costs. For instance, it would be possible to select 
regions with high versus low LOS and collect prospective data 
on the neonatal stay, including complications and healthcare, 
how the discharge decision was made for each child and the 
healthcare provided in the period after discharge. This could 
also permit use of time-varying models to understand how 
risk factors affect decisions across the neonatal course. A mixed 
method approach could complement these quantitative data 
with structured interviews of clinical decision-makers within 
the unit and with parents.
CONCLUSIONS
The large differences we found in LOS in hospital after very 
preterm birth among European regions could not be explained 
by infant characteristics. Although variation across regions 
narrowed from 2003 to 2011/2012, substantial differences 
remained. These raise questions about the diversity of cur-
rent practices as well as the weak evidence-base for inform-
ing clinical and health policy decisions on the optimal hospital 
stays for these high-risk infants. They also raise questions 
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about whether some care strategies may make it possible to 
achieve shorter LOS. Finally, understanding how differences in 
LOS affect readmissions, infant health, family well-being, and 
healthcare costs is an area for future research and could pro-
vide a basis for best practice guidelines.
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